(1)
Hassan, M.; Merza, N.; Nawras, Y.; Alfatlawi, H.; al obaidi, hasan; Saab, O.; Al Zubaidi, K.; Al-sabbagh, D.; mansur, S.; Algodi, M.; Al Najafi, O.; Matbachi, R.; Al Hamdany, T.; Noori, Z.; Kobeissy, A. Effect of Pemafibrate, a Selective Peroxisome Proliferator-Activated Receptor ? Modulator (SPPARM?), on the Lipid Profile, Liver Function, and Liver Fibrosis Among Patients With Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Translation 2025, 13.